Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 35.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 0
  • Market Cap: £189.14m
  • RiskGrade: 119

Regulatory News

Total Voting Rights 02-Oct-2023 15:14 RNS
Interim Results 26-Sep-2023 07:00 RNS
Notification of Major Holdings 22-Sep-2023 17:28 RNS
Notification of Major Holdings 04-Sep-2023 13:19 RNS
Notification of Major Holdings 30-Aug-2023 16:29 RNS
Notification of Major Holdings 29-Aug-2023 11:32 RNS
Notification of Major Holdings 15-Aug-2023 13:55 RNS
Notification of Half Year Results 10-Aug-2023 07:00 RNS
Director Dealing 20-Jul-2023 09:54 RNS
Director Dealings 19-Jul-2023 07:00 RNS
Half Year Trading Update 18-Jul-2023 07:00 RNS
Total Voting Rights 03-Jul-2023 15:05 RNS
Block Listing Six Monthly Return 29-Jun-2023 07:00 RNS
Total Voting Rights 01-Jun-2023 17:16 RNS
Result of AGM 25-May-2023 12:44 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 35.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 71.80
52 Week Low 34.50
Volume 0
Shares Issued 540.40m
Market Cap £189.14m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.56% above the market average84.56% above the market average84.56% above the market average84.56% above the market average84.56% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
69.61% below the market average69.61% below the market average69.61% below the market average69.61% below the market average69.61% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Income
9.02% above the market average9.02% above the market average9.02% above the market average9.02% above the market average9.02% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.94% below the market average88.94% below the market average88.94% below the market average88.94% below the market average88.94% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page